Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|February 25, 2020
The up-to-date role of biologics for the treatment of chronic lymphocytic leukemiaIwona Hus, Aleksander Salomon-Perzyński, Tadeusz Robak
Diagnostics (Basel, Switzerland)|September 28, 2021
Clonal Evolution of Multiple Myeloma-Clinical and Diagnostic ImplicationsAleksander Salomon-Perzyński, Krzysztof Jamroziak, Eliza Głodkowska-Mrówka
Expert Opinion on Pharmacotherapy|December 21, 2020
The management of hematologic malignancies during the COVID-19 pandemicIwona Hus, Aleksander Salomon-Perzyński, Krzysztof Tomasiewicz, et al.
Immunotargets and Therapy|February 22, 2019
Immunochemotherapy for Richter syndrome: current insightsBartosz Puła, Aleksander Salomon-Perzyński, Monika Prochorec-Sobieszek, et al.
Archives of Gynecology and Obstetrics|February 4, 2017
High-grade serous ovarian cancer: the clone warsAleksander Salomon-Perzyński, Magdalena Salomon-Perzyńska, Bogdan Michalski, et al.
Cancers|September 23, 2022
CRL4CRBN E3 Ligase Complex as a Therapeutic Target in Multiple MyelomaJoanna Barankiewicz, Aleksander Salomon-Perzyński, Irena Misiewicz-Krzemińska, et al.
Journal of Clinical Medicine|July 2, 2021
The CRBN, CUL4A and DDB1 Expression Predicts the Response to Immunomodulatory Drugs and Survival of Multiple Myeloma PatientsJoanna Barankiewicz, Anna Szumera-Ciećkiewicz, Aleksander Salomon-Perzyński, et al.
Chemotherapy|September 14, 2022
SARS-CoV-2 Infection in Patients Treated with Azacitidine and Venetoclax for Acute Leukemia: A Report of a Case Series Treated in a Single InstitutionJoanna Drozd-Sokołowska, Krzysztof Mądry, Joanna Barankiewicz, et al.
Polish Archives of Internal Medicine|April 28, 2020
The impact of cytogenetic evolution and acquisition of del(17p) on the prognosis of patients with multiple myelomaAleksander Salomon-Perzyński, Aleksandra Bluszcz, Agnieszka Krzywdzińska, et al.
International Journal of Molecular Sciences|November 27, 2024
Characterization and Experimental Use of Multiple Myeloma Bone Marrow Endothelial Cells and ProgenitorsFilip Garbicz, Marcin Kaszkowiak, Julia Dudkiewicz-Garbicz, et al.
Pageof 2